Gross Profit - Glenmark Life Sciences Ltd (NSE:GLS) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 826.4 INR 0.63%

Updated:

Glenmark Life Sciences Ltd
Gross Profit

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Glenmark Life Sciences Ltd
Gross Profit Peer Comparison

DRREDDY

CIPLA

SUNPHARMA

ZYDUSLIFE

T

TORNTPHARM

Company		Gross Profit	CAGR 3Y	CAGR 5Y	CAGR 10Y
G	Glenmark Life Sciences Ltd NSE:GLS	Gross Profit ₹12.8B	CAGR 3-Years 9%	CAGR 5-Years 19%	CAGR 10-Years N/A
	Dr Reddy's Laboratories Ltd NSE:DRREDDY	Gross Profit ₹198B	CAGR 3-Years 17%	CAGR 5-Years 14%	CAGR 10-Years N/A
	Cipla Ltd NSE:CIPLA	Gross Profit ₹169.5B	CAGR 3-Years 16%	CAGR 5-Years 12%	CAGR 10-Years 10%
	Sun Pharmaceutical Industries Ltd NSE:SUNPHARMA	Gross Profit ₹369.1B	CAGR 3-Years 15%	CAGR 5-Years 12%	CAGR 10-Years 11%
	Zydus Lifesciences Ltd NSE:ZYDUSLIFE	Gross Profit ₹123.7B	CAGR 3-Years 9%	CAGR 5-Years 8%	CAGR 10-Years 11%
T	Torrent Pharmaceuticals Ltd NSE:TORNTPHARM	Gross Profit ₹77.6B	CAGR 3-Years 10%	CAGR 5-Years 8%	CAGR 10-Years 11%

See Also

Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Gross Profit amounts to 12.8B INR.

Over the last year, the Gross Profit growth was 12%. The average annual Gross Profit growth rates for Glenmark Life Sciences Ltd have been 9% over the past three years , 19% over the past five years .

Join more than 137,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.